Ubrogepant effective for acute treatment of migraine when taken with onabotulinumtoxinAAugust 19, 2023Headache & Migraine
Add-on MIND outperforms treatment as usual in chronic migraine and medication-overuse headacheAugust 19, 2023Headache & Migraine
Triptans and ergotamine lower ischemic cardio-cerebrovascular diseases risk in migraineAugust 19, 2023Headache & Migraine
Anti-CGRP mAb equally effective when restarted in patients with migraineAugust 19, 2023Headache & Migraine
Study supports long-term benefits of galcanezumab in episodic migraineAugust 19, 2023Headache & Migraine
CGRP mAb can be used for migraine prevention in veterans at risk for COVID-19August 19, 2023Headache & Migraine
Commentary: Vasodilation, antihypertensive drugs, and caffeine in migraine, August 2023August 9, 2023Headache & Migraine
Biofeedback Training Is a Good Alternative to Preventive Medication for Migraine and Tension-Type Headache July 24, 2023Headache & Migraine
Switch from anti-CGRP receptor to anti-CGRP ligand mAb offers promise in treatment-refractory chronic migraineJuly 22, 2023Headache & Migraine
Monthly or quarterly fremanezumab shows favorable efficacy and tolerability in migraineJuly 22, 2023Headache & Migraine
Long-term erenumab shows sustained efficacy and safety in chronic migraineJuly 22, 2023Headache & Migraine
